Autoimmune symptoms in idiopathic pulmonary fibrosis: Clinical significance

Clinical Respiratory Journal

Volumn 10, Issue 3, 2016, Pages 350-358

  Alhamad, Esam Hamad ^a   Cal, Joseph Galindo ^a   Alboukai, Ahmad Amer ^a   Shaik, Shaffi Ahmed ^a   Omair, Mohammed Ahmed ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Autoantibodies; Autoimmune; Idiopathic pulmonary fibrosis; Undifferentiated connective tissue

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN; DOUBLE STRANDED DNA ANTIBODY; HISTIDINE TRANSFER RNA LIGASE; IMMUNOMODULATING AGENT; JO 1 ANTIBODY; LA ANTIBODY; MYCOPHENOLATE MOFETIL; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY;

AGED; ALOPECIA; ARTHRALGIA; ARTICLE; AUTOIMMUNE DISEASE; BRONCHIECTASIS; CONTROLLED STUDY; COUGHING; CRACKLE; DISEASE DURATION; DRY EYE; DYSPHAGIA; EMPHYSEMA; FEMALE; FEVER; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; JOINT SWELLING; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; MORTALITY RATE; MOUTH ULCER; MUSCLE WEAKNESS; PHOTOSENSITIVITY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RASH; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SEROLOGY; SMOKING; SPIROMETRY; SPUTUM; SURVIVAL TIME; SYMPTOM; SYMPTOMATOLOGY; THORAX PAIN; WEIGHT REDUCTION; XEROSTOMIA; AUTOIMMUNITY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE;

AGED; AUTOIMMUNE DISEASES; AUTOIMMUNITY; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84962747429     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12224     Document Type: Article

References (25)

1. Raghu G, Collard HR, Egan JJ, etal. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6): 788-824.
2. Navaratnam V, Ali N, Smith CJ, McKeever T, Fogarty A, Hubbard RB. Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis? Respir Med. 2011;105(12): 1925-1930.
3. Song JW, Do KH, Kim MY, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest. 2009;136(1): 23-30.
4. Fischer A, Pfalzgraf FJ, Feghali-Bostwick CA, Wright TM, Curran-Everett D, West SG, Brown KK. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis. J Rheumatol. 2006;33(8): 1600-1605.
5. Lee JS, Kim EJ, Lynch KL, etal. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med. 2013;107(2): 249-255.
6. Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011;140(5): 1292-1299.
7. Corte TJ, Copley SJ, Desai SR, etal. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J. 2012;39(3): 661-668.
8. Kinder BW, Collard HR, Koth L, etal. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007;176(7): 691-697.
9. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2): 277-304.
10. Macintyre N, Crapo RO, Viegi G, etal. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4): 720-735.
11. Miller MR, Hankinson J, Brusasco V, etal. Standardisation of spirometry. Eur Respir J. 2005;26(2): 319-338.
12. Wanger J, Clausen JL, Coates A, etal. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3): 511-522.
13. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1): 111-117.
14. Alhamad EH, Al-Boukai AA, Al-Kassimi FA, etal. Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of CT findings. Radiology. 2011;260(3): 875-883.
15. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest. 2010;138(2): 251-256.
16. LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum. 1980;23(3): 341-343.
17. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol. 1999;17(5): 615-620.
18. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol. 2005;32(2): 213-215.
19. Mosca M, Tani C, Talarico R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases. Autoimmun Rev. 2011;10(5): 256-258.
20. Travis WD, Costabel U, Hansell DM, etal. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6): 733-748.
21. Romagnoli M, Nannini C, Piciucchi S, etal. Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Eur Respir J. 2011;38(2): 384-391.
22. Suda T, Kono M, Nakamura Y, etal. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir Med. 2010;104(10): 1527-1534.
23. Kang BH, Park JK, Roh JH, etal. Clinical significance of serum autoantibodies in idiopathic interstitial pneumonia. J Korean Med Sci. 2013;28(5): 731-737.
24. Moua T, Maldonado F, Decker PA, Daniels CE, Ryu JH. Frequency and implication of autoimmune serologies in idiopathic pulmonary fibrosis. Mayo Clin Proc. 2014;89(3): 319-326.
25. Fischer A, Swigris JJ, du Bois RM, etal. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med. 2009;103(11): 1719-1724.